Biotech · Cambridge, MA · Founded 2022 · Privately Held (backing)
Developer of targeted immunotherapies designed for the treatment of autoimmune and allergic diseases. Merida Biosciences is based in Cambridge, MA and was founded in 2022. It was valued at $228 million at its early-stage round in Apr 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $121 million Series A in Apr 2025.
These 6 firms already write checks for companies like Merida Biosciences in biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.